How many institutions held OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in Q1 2020?

56 institutional investors reported OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share for Q1 2020. Use the holders table for investor-level position and value details.

Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

Q: What does CUSIP 690469101 represent in this 13F holders report?

CUSIP 690469101 is the security identifier for OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 690469101

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 134,553,130
Total 13F shares: 15,867,223
Share change: -1,885,873
Total reported value: $47,289,209
Price per share: $2.98
Number of holders: 56
Value change: -$7,210,519
Number of buys: 27
Number of sells: 32

Quarterly Holders Quick Answers

What is CUSIP 690469101?
CUSIP 690469101 identifies OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 690469101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Consonance Capital Management LP	13F	Company	2.1%	2,888,888	$11,989,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	1.5%	2,084,900	$8,652,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	1.1%	1,488,529	$6,177,000	—	31 Dec 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.81%	1,084,709	$4,502,000	—	31 Dec 2019	13F
AXA S.A.	13F	Company	0.64%	867,602	$3,601,000	—	31 Dec 2019	13F
CHI Advisors LLC	13F	Company	0.63%	843,931	$3,502,000	—	31 Dec 2019	13F
BVF INC/IL	13F	Company	0.55%	734,301	$3,047,000	—	31 Dec 2019	13F
CITIGROUP INC	13F	Company	0.37%	501,462	$2,081,000	—	31 Dec 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.35%	473,633	$1,966,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	0.33%	450,746	$1,871,000	—	31 Dec 2019	13F
Tekla Capital Management LLC	13F	Company	0.28%	372,733	$1,547,000	—	31 Dec 2019	13F
Ikarian Capital, LLC	13F	Company	0.26%	350,000	$1,453,000	—	31 Dec 2019	13F
Granite Point Capital Management, L.P.	13F	Company	0.26%	348,263	$1,445,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.25%	342,176	$1,420,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.24%	319,837	$1,327,000	—	31 Dec 2019	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.23%	306,146	$1,271,000	—	31 Dec 2019	13F
AWH Capital, L.P.	13F	Company	0.23%	305,000	$1,266,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.21%	287,929	$1,194,000	—	31 Dec 2019	13F
Informed Momentum Co LLC	13F	Company	0.21%	285,065	$1,183,000	—	31 Dec 2019	13F
CREDIT SUISSE AG/	13F	Company	0.2%	272,062	$1,129,000	—	31 Dec 2019	13F
Sio Capital Management, LLC	13F	Company	0.2%	264,581	$1,098,000	—	31 Dec 2019	13F
Qube Research & Technologies Ltd	13F	Company	0.19%	251,262	$1,043,000	—	31 Dec 2019	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.18%	242,600	$1,007,000	—	31 Dec 2019	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.17%	228,360	$947,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.16%	219,729	$912,000	—	31 Dec 2019	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.14%	190,253	$790,000	—	31 Dec 2019	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.13%	168,602	$700,000	—	31 Dec 2019	13F
ExodusPoint Capital Management, LP	13F	Company	0.11%	147,740	$613,000	—	31 Dec 2019	13F
Fairpointe Capital LLC	13F	Company	0.11%	141,700	$588,000	—	31 Dec 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.09%	127,117	$528,000	—	31 Dec 2019	13F
Redmile Group, LLC	13F	Company	0.09%	121,950	$506,000	—	31 Dec 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.09%	116,335	$483,000	—	31 Dec 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.07%	90,701	$376,000	—	31 Dec 2019	13F
Laurion Capital Management LP	13F	Company	0.07%	90,236	$374,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.06%	85,512	$355,000	—	31 Dec 2019	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.06%	75,738	$314,000	—	31 Dec 2019	13F
Virtu Financial LLC	13F	Company	0.05%	73,511	$305,000	—	31 Dec 2019	13F
Assenagon Asset Management S.A.	13F	Company	0.05%	65,906	$274,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.04%	50,821	$211,000	—	31 Dec 2019	13F
One68 Global Capital, LLC	13F	Company	0.04%	50,662	$210,000	—	31 Dec 2019	13F
683 Capital Management, LLC	13F	Company	0.03%	42,088	$175,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	38,088	$158,000	—	31 Dec 2019	13F
A.R.T. Advisors, LLC	13F	Company	0.03%	35,162	$146,000	—	31 Dec 2019	13F
Squarepoint Ops LLC	13F	Company	0.02%	26,029	$108,000	—	31 Dec 2019	13F
Cubist Systematic Strategies, LLC	13F	Company	0.02%	25,991	$108,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.02%	23,165	$96,000	—	31 Dec 2019	13F
ALGERT GLOBAL LLC	13F	Company	0.01%	19,590	$81,000	—	31 Dec 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.01%	19,200	$80,000	—	31 Dec 2019	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	19,063	$79,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.01%	18,578	$78,000	—	31 Dec 2019	13F

Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q1 2020

As of 31 Mar 2020, Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,867,223 shares. The largest 10 holders included Consonance Capital Management LP, FMR LLC, VANGUARD GROUP INC, BVF INC/IL, RENAISSANCE TECHNOLOGIES LLC, CHI Advisors LLC, AXA, BlackRock Inc., WELLS FARGO & COMPANY/MN, and MILLENNIUM MANAGEMENT LLC. This page lists 56 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

Q1 2020 holders

Holder diff

-2

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.